Company Filing History:
1 out of 917 
1 out of 3,539 
Years Active: 2023
Title: Innovations by Alexandra Fowler
Introduction
Alexandra Fowler is an accomplished inventor based in Albuquerque, NM (US). She has made significant contributions to the field of biotechnology, particularly in the development of compositions and methods aimed at reducing serum triglycerides. Her innovative work has the potential to impact health and wellness significantly.
Latest Patents
Fowler holds a patent for "Compositions and methods for reducing serum triglycerides." This patent describes an immunogen that generally includes a virus-like particle and an antigen linked to the virus-like particle. The antigen comprises an antigenic portion of a polypeptide that inhibits lipoprotein lipase (LPL) activity by binding to LPL. In various embodiments, the polypeptide may include portions of angiopoietin-like 3 (ANGPTL3), angiopoietin-like 4 (ANGPTL4), or angiopoietin-like 8 (ANGPTL8). The virus-like particle can be a Qbeta immunogenic carrier, with the antigen linked through a Gly-Gly-Gly-Cys linker at the C-terminal of the antigen.
Career Highlights
Throughout her career, Alexandra Fowler has worked with notable organizations such as UNM Rainforest Innovations and the National Institutes of Health, a component of the US Department of Health & Human Services. Her work in these institutions has allowed her to advance her research and contribute to significant scientific discoveries.
Collaborations
Fowler has collaborated with esteemed colleagues, including Bryce Chackerian and Alan Thomas Remaley. These partnerships have enriched her research and expanded the impact of her innovations.
Conclusion
Alexandra Fowler's contributions to biotechnology and her innovative patent for reducing serum triglycerides highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in health and wellness.